Precision BioSciences prices $40M public offering of 2.5M shares and warrants at $16/unit

PRECISION BIOSCIENCES INC

Offering of 2,500,000 common shares and warrants to purchase another 2,500,000 shares at $16.00 per unit.
Warrants have $20.00 exercise price, are immediately exercisable, and expire in 5 years.
Gross proceeds of $40.0M; net proceeds estimated at ~$37.1M after underwriting discounts.
Proceeds to fund R&D and general corporate purposes; closing expected March 5, 2024.
Participants include Perceptive Advisors, Janus Henderson, Aquilo Capital, LYFE Capital; Guggenheim sole book-runner.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.